Skip to Content
Merck

MMP-2 and 9 in Chronic Kidney Disease.

International journal of molecular sciences (2017-04-12)
Zhengyuan Cheng, Manoj Hang Limbu, Zhi Wang, Jing Liu, Lei Liu, Xiaoyi Zhang, Pingsheng Chen, Bicheng Liu
ABSTRACT

Gelatinases are members of the matrix metalloproteinase (MMPs) family; they play an important role in the degradation of the extracellular matrix (ECM). This effect is also crucial in the development and progression of chronic kidney disease (CKD). Its expression, as well as its activity regulation are closely related to the cell signaling pathways, hypoxia and cell membrane structural change. Gelatinases also can affect the development and progression of CKD through the various interactions with tumor necrosis factors (TNFs), monocyte chemoattractant proteins (MCPs), growth factors (GFs), oxidative stress (OS), and so on. Currently, their non-proteolytic function is a hot topic of research, which may also be associated with the progression of CKD. Therefore, with the in-depth understanding about the function of gelatinases, we can have a more specific and accurate understanding of their role in the human body.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
MMP-2 pre-activated human, recombinant, ≥1,000 pmol/min/μg, expressed in HEK 293 cells
Sigma-Aldrich
MMP-2 human, recombinant, ≥1,000 pmol/min/μg, expressed in HEK 293 cells